Rafal Dziadziuszko - Biography#

Prof. Rafał Dziadziuszko completed his MD (1994) and PhD (2003) at the Medical University of Gdansk. He received board certifications in Radiotherapy (2001) and Medical Oncology (2004). Between 2005 and 2007, he completed translational cancer research fellowship at the University of Colorado Cancer Center. He worked there on predictive assays for EGFR-targeted therapies in lung cancer, including immunohistochemistry, gene copy number, and activating mutations. His fellowships were funded by the International Union Against Cancer and the International Association for the Study of Lung Cancer. He then returned to his home institution to serve as a deputy chair of the department. Between 2013 and 2018, he served as the National Consultant for Radiation Oncology.

Prof. Dziadziuszko’s main interests include lung cancer translational and clinical research. He is a co-author of over 180 peer-reviewed articles and book chapters on this topic, including the Lung Cancer chapter in the 2016 edition of Oxford Textbook of Oncology. He is a member of the European Society for Medical Oncology, International Association for the Study of Lung Cancer, European Organisation for Research and Treatment of Cancer – Lung Cancer Group, European Society for Radiotherapy and Oncology, and associate editor of Journal of Thoracic Oncology and ESMO Open - Cancer Horizons. He has also participated in the organisation of several academic clinical research studies in Poland and Central Europe and serves as the deputy chair of the Central and East European Oncology Group. In 2017, he received the prestigious Heine H. Hansen Award for global contribution to lung cancer research and care.

His current work includes the identification of novel molecular targets for early lung cancer trials, evaluation of novel radiotherapy strategies in thoracic malignancies, and research on lung cancer screening programs.